A detailed history of Polar Asset Management Partners Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 22,700 shares of GH stock, worth $685,767. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,700
Previous 134,000 83.06%
Holding current value
$685,767
Previous $3.87 Million 86.56%
% of portfolio
0.02%
Previous 0.12%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $2.48 Million - $4.04 Million
-111,300 Reduced 83.06%
22,700 $520,000
Q2 2024

Aug 14, 2024

SELL
$16.07 - $31.84 $768,146 - $1.52 Million
-47,800 Reduced 26.29%
134,000 $3.87 Million
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $3.11 Million - $4.89 Million
181,800 New
181,800 $3.75 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $3.61 Million - $6.56 Million
172,600 New
172,600 $6.18 Million
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $3.64 Million - $8.54 Million
-142,900 Reduced 82.89%
29,500 $802,000
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $5.34 Million - $7.47 Million
-122,400 Reduced 41.52%
172,400 $9.28 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $8.5 Million - $22.8 Million
294,800 New
294,800 $11.9 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $1.9 Million - $3.95 Million
-39,300 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $1.36 Million - $1.84 Million
15,300 Added 63.75%
39,300 $3.93 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $2.37 Million - $3.17 Million
24,000 New
24,000 $3 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.09B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.